JCB, Volume 8, Number 1, 2001 Editorial Vol.8 No. 1 (2001) A civic duty John M Sime   Commentary Vol.8 No. 1 (2001) Lessons learned Jeremy Curnock Cook Presents an article which narrates the experience of being an investment manager in the biotechnology industry. Challenge of sustaining and maintenance of investor confide Article Vol.8 No. 1 (2001) Becoming a premier partner: Measuring, managing and changing partnering capabilities at Eli Lilly and Company David Futrell When Eli Lilly and Company decided to expand its drug development by entering into strategic 'alliances' with other, usually smaller, biotechnology firms, the company committed to be Article Vol.8 No. 1 (2001) Solid organ xenotransplantation: Progress, promise and regulatory issues Julia L Greenstein Xenotransplantation, the process of transplanting live cells, tissues and organs from one species into another, is an emerging novel area in medicine. It is proposed as Article Vol.8 No. 1 (2001) The human stem cells debate: A UK perspective Tor Lezemore The potential use of embryonic stem cells for the treatment of common diseases raises a number of ethical concerns relating to the use of embryos in research and the possibility of h Article Vol.8 No. 1 (2001) The European Clinical Trials Directive: What does this mean for the biopharmaceutical industry? Simon Bryson 1st May, 2001, saw the final publication of the long-anticipated European Union Directive relating to Good clinical practice in the conduct of clinical trials on medicinal products f Article Vol.8 No. 1 (2001) Biomanufacturing capacity: Current and future requirements Andrew Sinclair In recent years the perception has arisen that biopharmaceuticals manufacturing capacity has gone from excess to shortage. What is the cause of this change and why were th Article Vol.8 No. 1 (2001) Strategies for improving communication between scientists and the public Belinda R Clarke It is believed that a scientifically literate society benefits the national economy by improving the workforce and raising consumer awareness by helping people appreciate and support Article Vol.8 No. 1 (2001) Key indicators of the German equipment and supplies industry Stefan Woerner A framework is presented to analyse the sector of equipment and supplies in biotechnology. Unlike the much-studied sectors of agro-food and biopharmaceuticals, the biotec Article Vol.8 No. 1 (2001) Cell therapy: European legal and regulatory implications Scott Parker This paper reviews some of the legal and regulatory considerations that may arise in connection with the use in Europe of cell therapy approaches for the treatment of disease. Legal and Regulatory Updates Vol.8 No. 1 (2001) Legal and Regulatory Update John Wilkinson   Legal and Regulatory Updates Vol.8 No. 1 (2001) EU Financial accounts reports David Citron   Legal and Regulatory Updates Vol.8 No. 1 (2001) US Financial accounts reports Glenn Crocker  Â
